Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUSTAIN: MRSA Decolonization in HIV Patients and Households
NCT02029872Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2014
- Primary completion
- Mar 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mupirocin, chlorhexidine in Methicillin-resistant Staphylococcus aureus colonization, sponsored by Johns Hopkins University. Started Jan 2014; status: completed.
02
Drugs
mupirocinchlorhexidine
03
Conditions
Methicillin-resistant Staphylococcus aureus colonization
Beyond the preview
Go deeper on NCT02029872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029872.